Crystal structure of human bone morphogenetic protein-2 at 2.7 Å resolution

Journal of Molecular Biology

Volumn 287, Issue 1, 1999, Pages 103-115

  Scheufler, Clemens ^a   Sebald, Walter ^a   Hülsmeyer, Martin ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

BMP 2; Bone morphogenetic protein; Cystine knot; TGF family; X ray crystallography

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ARTICLE; CRYSTAL STRUCTURE; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE;

DUDLEYA EDULIS; VERTEBRATA;

EID: 0033582942     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.2590     Document Type: Article

References (65)

1. Brunger A. T. Crystallographic refinement by simulated annealing. Acta Crystallog. sect. A. 45:1989;50-61.
2. Brunger A. T. Extension of molecular replacement: A new strategy based on Patterson correlation refinement. Acta Crystallog. sect. A. 46:1990;46-57.
3. Brunger A. T. Free R Value: cross-validation in crystallography. Methods Enzymol. 277:1997;366-396.
4. Brunger A. T., Adams P. D., Clore G. M., DeLano W. L., Gros P., Grosse-Kunstleve R. W., Jiang J.-S., Kuszewski J., Nilges M., Pannu N. S., Read R. J., Rice L. M., Simonson T., Warren G. L. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallog. sect. D. 54:1998;905-921.
5. CCP4. The CCP4-suite: programs for crystallography. Acta Crystallog. sect. A. 50:1994;760-763.
6. Carson M., Bugg C. E. Algorithm for ribbon models of proteins. J. Mol. Graph. 4:1986;121-122.
7. Celeste A. J., Iannazzi J. A., Taylor R. C., Hewick R. M., Rosen V., Wang E. A., Wozney J. M. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc. Natl Acad. Sci. USA. 87:1990;9843-9847.
8. Chalaux E., Lopez Rovira T., Rosa J. L., Bartrons R., Ventura F. JunB is involved in the inhibition of myogenic differentiation by bone morphogenetic protein-2. J. Biol. Chem. 273:1998;537-543.
9. Cudney B., Patel S., Weisgraber K., Newhouse Y., McPhearson A. Screening and optimization strategies for macromolecular crystal growth. Acta Crystallog. sect. D. 50:1994;141-423.
10. Daopin S., Piez K. A., Ogawa Y., Davies D. R. Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily. Science. 257:1992;369-373.
11. Davies D. R., Cohen G. H. Interactions of protein antigens with antibodies. Proc. Natl Acad. Sci. USA. 93:1996;7-12.
12. Dudley A. T., Lyons K. M., Robertson E. J. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev. 9:1995;2795-2807.
13. Estevez M., Attisano L., Wrana J. L., Albert P. S., Massague J., Riddle D. L. The daf-4 gene encodes a bone morphogenetic protein receptor controlling C. elegans dauer larva development. Nature. 365:1993;644-649.
14. Wisconsin Package, Version 9.1. 1997;Genetics Computer Group (GCG), Madison.
15. Goetschy J. F., Letourneur O., Cerletti N., Horisberger M. A. The unglycosylated extracellular domain of type-II receptor for transforming growth factor-beta. A novel assay for characterizing ligand affinity and specificity. Eur. J. Biochem. 241:1996;355-362.
16. Griffith D. L., Keck P. C., Sampath T. K., Rueger D. C., Carlson W. D. Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily. Proc. Natl Acad. Sci. USA. 93:1996;878-883.
17. Hinck A. P., Archer S. J., Qian S. W., Roberts A. B., Sporn M. B., Weatherbee J. A., Tsang M. L., Lucas R., Zhang B. L., Wenker J., Torchia D. A. Transforming growth factor beta 1: three-dimensional structure in solution and comparison with the X-ray structure of transforming growth factor beta 2. Biochemistry. 35:1996;8517-8534.
18. Hogan B. L. M. Bone morphogenetic proteins in development. Curr. Opin. Genet. Dev. 6:1996;432-438.
19. Israel D. I., Nove J., Kerns K. M., Moutsatsos I. K., Kaufman R. J. Expression and characterization of bone morphogenetic protein-2 in Chinese hamster ovary cells. Growth Factors. 7:1992;139-150.
20. Jancarik J., Kim S. H. Sparse matrix sampling: a screning method for crystallization of proteins. J. Appl. Crystallog. 24:1991;409-411.
21. Janin J., Chothia C. The structure of protein-protein recognition sites. J. Biol. Chem. 265:1990;16027-16030.
22. Jones T. A., Zou J. Y., Cowtan S. W., Kjelgaard M. Improved methods for building protein in electron density maps and location of errors in these models. Acta Crystallog. sect. A. 47:1991;110-119.
23. Kabsch W. Automatic processing of rotation diffraction data from crystals of initially known symmetry and cell constants. J. Appl. Crystallog. 26:1993;795-800.
24. Kabsch W., Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 22:1983;2577-2637.
25. Kingsley D. M. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8:1994;133-146.
26. Koenig B. B., Cook J. S., Wolsing D. H., Ting J., Tiesman J. P., Correa P. E., Olson C. A., Pecquet A. L., Ventura F., Grant R. A. et al. Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells. Mol. Cell. Biol. 14:1994;5961-5974.
27. Kossiakoff A. A., Randal M., Guenot J., Eigenbrot C. Variability of conformations at crystal contacts in BPTI represent true low-energy structures: correspondence among lattice packing and molecular dynamics structures. Proteins: Struct. Funct. Genet. 14:1992;65-74.
28. Kübler N. R., Reuther J. F., Faller G., Kirchner T., Ruppert R., Sebald W. Inductive properties of recombinant human BMP-2 produced in a bacterial expression system. Int. J. Oral Maxillofacial Surg. 27:1998;305-309.
29. Laskowski R. A., MacArthur M. W., Moss D. S., Thornton M. J. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallog. 26:1992;283-291.
30. Lindahl U., Kjellen L. Heparin or heparan sulfate - what is the difference? Thromb. Haemost. 66:1991;44-48.
31. Liu F., Ventura F., Doody J., Massague J. Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol. Cell. Biol. 15:1995;3479-3486.
32. Lu W. A WWW service system for automatic comparison of protein structures. Protein Data Bank Quart. Newsletter. 78:1996;10-11.
33. Luo G., Hofmann C., Bronckers A. L., Sohocki M., Bradley A., Karsenty G. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev. 9:1995;2808-2820.
34. Martinez Barbera J. P., Toresson H., Da Rocha S., Krauss S. Cloning and expression of three members of the zebrafish Bmp family: Bmp2a, Bmp2b and Bmp4. Gene. 198:1997;53-59.
35. Matthews B. W. Solvent content of protein crystals. J. Mol. Biol. 33:1968;491-497.
36. McDonald N. Q., Hendrickson W. A. A structural superfamily of growth factors containing a cystine knot motif. Cell. 73:1993;421-424.
37. Mittl P. R., Priestle J. P., Cox D. A., McMaster G., Cerletti N., Grutter M. G. The crystal structure of TGF-beta 3 and comparison to TGF-beta 2: implications for receptor binding. Protein Sci. 5:1996;1261-1271.
38. Miya T., Morita K., Suzuki A., Ueno N., Satoh N. Functional analysis of an ascidian homologue of vertebrate Bmp-2/Bmp-4 suggests its role in the inhibition of neural fate specification. Development. 124:1997;5149-5159.
39. Muller Y. A., Christinger H. W., Keyt B. A., de Vos A. M. The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 Å resolution: multiple copy flexibility and receptor binding. Structure. 5:1997a;1325-1338.
40. Muller Y. A., Li B., Christinger H. W., Wells J. A., Cunningham B. C., de Vos A. M. Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site. Proc. Natl Acad. Sci. USA. 94:1997b;7192-7197.
41. Murray-Rust J., McDonald N. Q., Blundell T. L., Hosang M., Oefner C., Winkler F., Bradshaw R. A. Topological similarities in TGF-beta 2, PDGF-BB and NGF define a superfamily of polypeptide growth factors. Structure. 1:1993;153-159.
42. Newfeld S. J., Padgett R. W., Findley S. D., Richter B. G., Sanicola M., de Cuevas M., Gelbart W. M. Molecular evolution at the decapentaplegic locus in Drosophila. Genetics. 145:1997;297-309.
43. Nicholls A., Sharp K. A., Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins: Struct. Funct. Genet. 11:1991;281-296.
44. Oefner C., D'Arcy A., Winkler F. K., Eggimann B., Hosang M. Crystal structure of human platelet-derived growth factor BB. EMBO J. 11:1992;3921-3926.
45. Ozkaynak E., Rueger D. C., Drier E. A., Corbett C., Ridge R. J., Sampath T. K., Oppermann H. OP-1 cDNA encodes an osteogenic protein in the TGF-beta family. EMBO J. 9:1990;2085-2093.
46. Plessow S., Koster M., Knochel W. cDna sequence of Xenopus laevis bone morphogenetic protein 2 (Bmp-2). Biochim. Biophys. Acta. 1089:1991;280-282.
47. Ramachandran G. N., Sasisekharan V. Conformation of polypeptides and proteins. Advan. Protein Chem. 23:1968;283-438.
48. Reddi A. H. Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens. Cytokine Growth Factor Rev. 8:1997;11-20.
49. Ruppert R., Hoffmann E., Sebald W. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur. J. Biochem. 237:1996;295-302.
50. Sampath T. K., Reddi A. H. Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation. Proc. Natl Acad. Sci. USA. 78:1981;7599-7603.
51. Schlunegger M. P., Grutter M. G. An unusual feature revealed by the crystal structure at 2.2 Å resolution of human transforming growth factor-beta 2. Nature. 358:1992;430-434.
52. Schlunegger M. P., Grutter M. G. Refined crystal structure of human transforming growth factor beta 2 at 1.95 A resolution. J. Mol. Biol. 231:1993;445-458.
53. Schomburg D., Reichelt J. BRAGI: a comprehensive protein modelling system. J. Mol. Graph. 6:1988;161-165.
54. Sibanda B. L., Thornton J. M. Conformation of beta hairpins in protein structures: classification and diversity in homologous structures. Methods Enzymol. 202:1991;59-82.
55. Stoesser G., Sterk P., Tuli M. A., Stoehr P. J., Cameron G. N. The EMBL Nucleotide Sequence Database. Nucl. Acids Res. 25:1997;7-14.
56. ten Dijke P., Yamashita H., Ichijo H., Franzen P., Laiho M., Miyazono K., Heldin C. H. Characterization of type I receptors for transforming growth factor-beta and activin. Science. 264:1994a;101-104.
57. ten Dijke P., Yamashita H., Sampath T. K., Reddi A. H., Estevez M., Riddle D. L., Ichijo H., Heldin C. H., Miyazono K. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 269:1994b;16985-16988.
58. Tong L., Rossmann M. G. The locked rotation function. Acta Crystallog. sect. A. 46:1990;783-792.
59. Urist M. R. Bone: formation by autoinduction. Science. 150:1965;893-899.
60. Wang E. A., Rosen V., D'Alessandro J. S., Bauduy M., Cordes P., Harada T., Israel D. I., Hewick R. M., Kerns K. M., LaPan P. et al. Recombinant human bone morphogenetic protein induces bone formation. Proc. Natl Acad. Sci. USA. 87:1990;2220-2224.
61. Wiesmann C., Fuh G., Christinger H. W., Eigenbrot C., Wells J. A., de Vos A. M. Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell. 91:1997;695-704.
62. Wozney J. M., Rosen V., Celeste A. J., Mitsock L. M., Whitters M. J., Kriz R. W., Hewick R. M., Wang E. A. Novel regulators of bone formation: molecular clones and activities. Science. 242:1988;1528-1534.
63. Wrana J. L., Attisano L., Wieser R., Ventura F., Massague J. Mechanism of activation of the TGF-beta receptor. Nature. 370:1994;341-347.
64. Yamashita H., ten Dijke P., Huylebroeck D., Sampath T. K., Andries M., Smith J. C., Heldin C. H., Miyazono K. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J. Cell Biol. 130:1995;217-226.
65. Zhang H., Bradley A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development. 122:1996;2977-2986.